More tools:Markets·Screener·Research·Chat

Utah Medical Products Inc (UTMD) Financial Statements

Utah Medical Products Inc
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001S6PWD1
XNAS · usd
69.16▼ 1.94 (-2.73%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close71.10
Day's Range68.46 – 70.50
52-Week Range53.37 – 75.75
Volume28.0K
Avg Volume32.6K
Share Statistics
Shares Outstanding
Employees152
ExchangeXNAS
Listed1982-12-01
Share count as of August 11, 2026
Loading Income Statement…
Key questions about Utah Medical Products Inc (UTMD)
What is Utah Medical Products Inc's Market Cap?
Utah Medical Products Inc's Market Cap is $220.2M, based on as-reported figures from SEC (XBRL) filings.
What is Utah Medical Products Inc's Enterprise Value?
Utah Medical Products Inc's Enterprise Value is $132.9M, based on as-reported figures from SEC (XBRL) filings.
What is Utah Medical Products Inc's Trailing P/E?
Utah Medical Products Inc's Trailing P/E is 21.0×, based on as-reported figures from SEC (XBRL) filings.
What is Utah Medical Products Inc's Price / Sales?
Utah Medical Products Inc's Price / Sales is 6.1×, based on as-reported figures from SEC (XBRL) filings.
What is Utah Medical Products Inc's EV / Revenue?
Utah Medical Products Inc's EV / Revenue is 3.7×, based on as-reported figures from SEC (XBRL) filings.
What is Utah Medical Products Inc's EV / EBITDA?
Utah Medical Products Inc's EV / EBITDA is 11.0×, based on as-reported figures from SEC (XBRL) filings.
What is Utah Medical Products Inc's Revenue (TTM)?
Utah Medical Products Inc's Revenue (TTM) is $36.1M, based on as-reported figures from SEC (XBRL) filings.
What is Utah Medical Products Inc's Net Income (TTM)?
Utah Medical Products Inc's Net Income (TTM) is $10.5M, based on as-reported figures from SEC (XBRL) filings.
What is Utah Medical Products Inc's EBITDA?
Utah Medical Products Inc's EBITDA is $12.7M, based on as-reported figures from SEC (XBRL) filings.
What is Utah Medical Products Inc's Diluted EPS (TTM)?
Utah Medical Products Inc's Diluted EPS (TTM) is 3.29, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Details
Revenue
YoY growth-14.3%-10.2%-1.2%-1.9%
Cost of Revenue
Gross profit
% of revenue55.8%60.6%58.2%57.1%
Operating expense
Selling, General and Administrative Expense
Research and Development Expense
Total operating expenses—
% of revenue24.7%31.2%—30.5%
Operating income
% of revenue31.1%29.4%27.0%26.6%
Non-Operating Income (Expense)
Income before provision for income taxes
Income Tax Expense
Net income
% of revenue31.5%29.9%28.4%26.8%
Earnings per share, basic—
Earnings per common share (diluted)—